Clinical trials
5 active studies led by Idoven 1903 S.L., of 7 in all
Source: ClinicalTrials.gov, Studies with Idoven 1903 S.L. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 1Markets in public records
- 0Regions & countries
- 5Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Idoven 1903 S.L. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Idoven 1903 S.L.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies Idoven 1903 S.L. leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Idoven 1903 S.L. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Idoven 1903 S.L.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Healthcare Topics
The topics of the markets Idoven 1903 S.L. is in.
From our blog
Stories on the topics Idoven 1903 S.L. works in.
Health Data Exchange: Why EDI Matters for Payers and Providers
Behind every insurance claim is a standard electronic message. The CAQH Index says $20 billion a year could…
Read
Bioinformatics: Making Sense of Health Data
Sequencing a human genome fell from about $50 million in 2003 to under $1,500 by late 2015. Bioinformatics…
Read
Dermatology Diagnostics: AI and Skin Health
Skin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Read